| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| gabapentin | Capsule, hard | 400 mg | Current | Limited Availability | Manufacturing | 12/12/2025 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 12/12/2025 |
| clindamycin phosphate | Injection, solution | 0 QS | Anticipated | Available | Manufacturing | 12/12/2025 |
| aripiprazole | Tablet, uncoated | 10 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| tacrolimus monohydrate | Capsule, hard | 5.112 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet | .25 mg | Current | Limited Availability | Manufacturing | 12/12/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| cisatracurium besilate | Injection, solution | 14.07 mg | Current | Limited Availability | Manufacturing | 12/12/2025 |
| citalopram hydrobromide | Tablet, film coated | 49.98 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| carbidopa monohydrate~levodopa~entacapone | Tablet, film coated | 54.1 mg~200 mg~200 mg | Current | Unavailable | Unexpected increase in consumer demand | 12/12/2025 |
| Pegvisomant | Injection, powder for | 10 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 6.935 mg~40 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| lacosamide | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| lorazepam | Tablet | 1 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 12/12/2025 |
| timolol maleate~latanoprost | Eye Drops, solution | 6.83 mg/mL~.05 mg/mL | Current | Limited Availability | Manufacturing | 12/12/2025 |
| paroxetine hydrochloride | Tablet, film coated | 22.22 mg | Current | Limited Availability | Manufacturing | 12/12/2025 |
| ciprofloxacin hydrochloride | Tablet, film coated | 582.21 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| lamotrigine | Tablet, chewable | 100 mg | Current | Unavailable | Manufacturing | 12/12/2025 |
| lamotrigine | Tablet, chewable | 200 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| nitrofurantoin | Capsule, hard | 100 mg | Current | Limited Availability | Unexpected increase in consumer demand | 12/12/2025 |
| tofacitinib citrate | Solution | 1.62 mg/mL | Anticipated | Available | Manufacturing | 12/12/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Anticipated | Available | Manufacturing | 12/12/2025 |
| doxepin hydrochloride | Capsule, hard | 28.25 mg | Current | Limited Availability | Manufacturing | 12/12/2025 |
| clonidine hydrochloride | Tablet, uncoated | 150 microgram | Current | Limited Availability | Manufacturing | 12/12/2025 |
| salbutamol sulfate | Inhalation, conventional | 3 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| salbutamol sulfate | Inhalation, conventional | 6 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| salbutamol sulfate | Inhalation | 2.4 mg/mL | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 11/12/2025 |
| nortriptyline | Tablet, film coated | 10 mg | Resolved | Available | Manufacturing | 11/12/2025 |
| bisoprolol fumarate | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 9.972 mg | Current | Limited Availability | Manufacturing | 11/12/2025 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Resolved | Available | Manufacturing | 11/12/2025 |
| indapamide hemihydrate | Tablet, sugar coated | 2.5 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| montelukast sodium | Tablet, chewable | 4.16 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| enalapril maleate | Tablet | 5 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| levodopa~carbidopa monohydrate~entacapone | Tablet, film coated | 100 mg~27 mg~200 mg | Current | Unavailable | Unexpected increase in consumer demand | 11/12/2025 |
| ezetimibe | Tablet, uncoated | 10 mg | Current | Limited Availability | Unexpected increase in consumer demand | 11/12/2025 |
| irbesartan | Tablet, film coated | 150 mg | Anticipated | Available | Manufacturing | 11/12/2025 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Anticipated | Available | Manufacturing | 11/12/2025 |
| bimatoprost | Eye Drops | .3 mg/mL | Anticipated | Available | Manufacturing | 11/12/2025 |
| erenumab | Injection, solution | 70 mg | Current | Limited Availability | Unexpected increase in consumer demand | 11/12/2025 |
| crisaborole | Ointment | 2 % w/w | Anticipated | Available | Unexpected increase in consumer demand | 11/12/2025 |
| gabapentin | Tablet, film coated | 600 mg | Resolved | Available | Manufacturing | 11/12/2025 |
| sitagliptin hydrochloride monohydrate~metformin hydrochloride | Tablet, modified release | 56.685 mg~1000 mg | Current | Unavailable | Manufacturing | 11/12/2025 |
| nitrofurantoin | Capsule, hard | 50 mg | Anticipated | Available | Manufacturing | 11/12/2025 |
| Teriparatide | Injection, solution | .25 mg/mL | Anticipated | Available | Manufacturing | 11/12/2025 |
| levothyroxine sodium | Tablet, uncoated | .05 mg | Resolved | Available | Manufacturing | 11/12/2025 |
| rifampicin | Oral Liquid | 20 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 10/12/2025 |
| metformin hydrochloride | Tablet, film coated | 850 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| lansoprazole | Capsule, enteric | 30 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| lamivudine | Tablet, film coated | 300 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| lansoprazole | Tablet, orally disintegrating | 30 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| azithromycin | Injection, powder for | 500 mg | Current | Unavailable | Commercial Changes / Commercial viability | 10/12/2025 |
| ropivacaine hydrochloride | Injection, solution | 75 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 10/12/2025 |
| ropivacaine hydrochloride | Injection, solution | 200 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 10/12/2025 |
| lurasidone hydrochloride | Tablet, film coated | 80 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 10/12/2025 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| fluorouracil | Injection, solution | 50 mg/mL | Resolved | Available | Manufacturing | 10/12/2025 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| aprepitant | Capsule, hard | 165 mg | Anticipated | Available | Manufacturing | 10/12/2025 |
| montelukast sodium | Tablet, chewable | 5.2 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| perindopril erbumine | Tablet, uncoated | 2 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 10/12/2025 |
| perindopril erbumine | Tablet, uncoated | 4 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 10/12/2025 |
| levothyroxine sodium | Tablet, uncoated | 75 microgram | Current | Unavailable | Manufacturing | 10/12/2025 |
| levothyroxine sodium | Tablet, uncoated | 200 microgram | Current | Unavailable | Manufacturing | 10/12/2025 |
| tetrabenazine | Tablet, uncoated | 25 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| isotretinoin | Capsule, soft | 20 mg | Current | Unavailable | Manufacturing | 10/12/2025 |
| isotretinoin | Capsule, soft | 10 mg | Current | Limited Availability | Manufacturing | 10/12/2025 |
| stannous chloride dihydrate | Injection, powder for | 19.2 microgram/mL | Anticipated | Available | Manufacturing | 10/12/2025 |
| perindopril erbumine | Tablet, uncoated | 8 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 10/12/2025 |
| ceftazidime pentahydrate | Injection, powder for | 2.328 g | Resolved | Available | Manufacturing | 9/12/2025 |
| hydromorphone hydrochloride | Injection, solution | 10 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 9/12/2025 |
| prasugrel | Tablet, film coated | 5 mg | Resolved | Available | Commercial Changes / Commercial viability | 9/12/2025 |
| dantrolene sodium hemiheptahydrate | Capsule | 25 mg | Current | Unavailable | Manufacturing | 9/12/2025 |
| dantrolene sodium hemiheptahydrate | Capsule | 50 mg | Current | Unavailable | Manufacturing | 9/12/2025 |
| eptifibatide | Injection, solution | 20 mg | Current | Unavailable | Manufacturing | 9/12/2025 |
| mefloquine hydrochloride | Tablet, uncoated | 274.09 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 9/12/2025 |
| alprostadil | Injection, solution | 500 microgram/mL | Anticipated | Available | Manufacturing | 9/12/2025 |
| labetalol hydrochloride | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 9/12/2025 |
| desferrioxamine mesilate | Injection, powder for | 2 g | Anticipated | Available | Manufacturing | 9/12/2025 |
| betiatide | Injection, powder for | 1 mg | Current | Unavailable | Manufacturing | 8/12/2025 |
| drospirenone~ethinylestradiol | Tablet | 3 mg~30 microgram | Resolved | Available | Manufacturing | 8/12/2025 |
| milrinone | Injection, concentrated | 10 mg | Current | Unavailable | Manufacturing | 8/12/2025 |
| temozolomide | Capsule, hard | 20 mg | Anticipated | Available | Manufacturing | 8/12/2025 |
| paclitaxel | Injection, concentrated | 300 mg | Resolved | Available | Manufacturing | 8/12/2025 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Current | Limited Availability | Manufacturing | 8/12/2025 |
| pregabalin | Capsule, hard | 25 mg | Resolved | Available | Manufacturing | 8/12/2025 |
| lamotrigine | Tablet, uncoated | 100 mg | Current | Unavailable | Manufacturing | 8/12/2025 |
| hydrocortisone | Tablet, uncoated | 4 mg | Resolved | Available | Manufacturing | 8/12/2025 |
| levothyroxine sodium | Tablet, uncoated | 100 microgram | Current | Unavailable | Manufacturing | 8/12/2025 |
| levothyroxine sodium | Tablet, uncoated | 50 microgram | Current | Unavailable | Manufacturing | 8/12/2025 |
| thiotepa | Injection, powder for | 15 mg | Current | Unavailable | Commercial Changes / Commercial viability | 8/12/2025 |
| thiotepa | Injection, powder for | 100 mg | Current | Unavailable | Commercial Changes / Commercial viability | 8/12/2025 |
| thiotepa | Injection, powder for | 400 mg | Current | Unavailable | Commercial Changes / Commercial viability | 8/12/2025 |
| clopidogrel hydrogen sulfate | Tablet, film coated | 97.875 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 8/12/2025 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 8/12/2025 |
| bleomycin sulfate | Injection, powder for | 15000 IU | Resolved | Available | Manufacturing | 8/12/2025 |
| dexamethasone~framycetin sulfate~gramicidin | Ear Drops | .5 mg/mL~5 mg/mL~.05 mg/mL | Current | Limited Availability | Manufacturing | 8/12/2025 |
| pramipexole dihydrochloride monohydrate | Tablet, uncoated | .125 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 8/12/2025 |
| midazolam | Injection, solution | 1 mg/mL | Current | Unavailable | Manufacturing | 8/12/2025 |
| simvastatin | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 8/12/2025 |
2025年12月15日